Investor Relations Activities
A key focus of our Investor Relations activities is to inform private shareholders, institutional investors and research analysts comprehensively, transparently, promptly and on equal terms. Our aim is to enable market participants to form a realistic opinion of the company's profitability, strategic positioning and the associated opportunities and risks. Our quarterly financial reports and regular Investor News inform shareholders and analysts about the development of business and important events in the Fresenius Group. Our quarterly reports and annual reports also contain detailed segment reporting. Corporate strategy and current developments are discussed in depth with interested parties in numerous meetings, at company presentations and at analyst conferences.
The shares of our subsidiary Fresenius Medical Care are traded in Germany and, in the form of American Depositary Receipts (ADRs), on the New York Stock Exchange. If you are interested in the shares of Fresenius Medical Care, please contact:
Fresenius Medical Care
Investor Relations
in Germany:
Tel.: +49 (0) 6172-609-2525
in the USA:
Tel.: +1-800-948-2538
